Precision T1D Platform

NCT07594145 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
T1D Diabetic Chronic Kidney Disease
T1D Heart Failure
Cardio-renal Vascular Function and Failure

Interventions

DRUG: Finerenone
DRUG: Sotagliflozin

Sponsor

Oregon Health and Science University

Collaborators

[object Object]
[object Object]